Movatterモバイル変換

[0]ホーム
URL:

GB0607947D0 - Organic Compounds - Google Patents

Organic Compounds

Info

Publication number
GB0607947D0
GB0607947D0GB0607947AGB0607947AGB0607947D0GB 0607947 D0GB0607947 D0GB 0607947D0GB 0607947 AGB0607947 AGB 0607947AGB 0607947 AGB0607947 AGB 0607947AGB 0607947 D0GB0607947 D0GB 0607947D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0607947A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AGfiledCriticalNovartis AG
Priority to GB0607947ApriorityCriticalpatent/GB0607947D0/en
Publication of GB0607947D0publicationCriticalpatent/GB0607947D0/en
Priority to UAA200811313Aprioritypatent/UA94735C2/en
Priority to SI200730937Tprioritypatent/SI2013211T1/en
Priority to PT07724372Tprioritypatent/PT2013211E/en
Priority to PL07724372Tprioritypatent/PL2013211T3/en
Priority to MX2008013431Aprioritypatent/MX2008013431A/en
Priority to US12/297,291prioritypatent/US8258141B2/en
Priority to BRPI0710573-8Aprioritypatent/BRPI0710573A2/en
Priority to CA002649215Aprioritypatent/CA2649215A1/en
Priority to EP10192555.0Aprioritypatent/EP2322525B1/en
Priority to PT101925550Tprioritypatent/PT2322525E/en
Priority to ARP070101686Aprioritypatent/AR060607A1/en
Priority to PL10192555Tprioritypatent/PL2322525T3/en
Priority to RU2008145716/04Aprioritypatent/RU2457209C2/en
Priority to ES07724372Tprioritypatent/ES2384337T3/en
Priority to ES10192555.0Tprioritypatent/ES2440317T3/en
Priority to PE2007000482Aprioritypatent/PE20080361A1/en
Priority to AU2007241343Aprioritypatent/AU2007241343B2/en
Priority to MYPI20084072Aprioritypatent/MY146645A/en
Priority to AT07724372Tprioritypatent/ATE549337T1/en
Priority to NZ571429Aprioritypatent/NZ571429A/en
Priority to PCT/EP2007/003435prioritypatent/WO2007121920A2/en
Priority to JP2009505779Aprioritypatent/JP5373599B2/en
Priority to CN2007800231803Aprioritypatent/CN101472925B/en
Priority to EP07724372Aprioritypatent/EP2013211B1/en
Priority to KR1020087028413Aprioritypatent/KR20080110925A/en
Priority to DK07724372.3Tprioritypatent/DK2013211T3/en
Priority to CL200701131Aprioritypatent/CL2007001131A1/en
Priority to TW096114114Aprioritypatent/TW200808797A/en
Priority to ZA200808055Aprioritypatent/ZA200808055B/en
Priority to IL194396Aprioritypatent/IL194396A0/en
Priority to CR10335Aprioritypatent/CR10335A/en
Priority to GT200800219Aprioritypatent/GT200800219A/en
Priority to TNP2008000407Aprioritypatent/TNSN08407A1/en
Priority to EC2008008836Aprioritypatent/ECSP088836A/en
Priority to MA31369Aprioritypatent/MA30469B1/en
Priority to NO20084803Aprioritypatent/NO20084803L/en
Priority to HK09104459.7Aprioritypatent/HK1125642A1/en
Priority to US13/218,865prioritypatent/US8318750B2/en
Priority to US13/218,887prioritypatent/US20120004247A1/en
Priority to HRP20120494TTprioritypatent/HRP20120494T1/en
Priority to CY20121100544Tprioritypatent/CY1113063T1/en
Ceasedlegal-statusCriticalCurrent

Links

GB0607947A2006-04-212006-04-21Organic CompoundsCeasedGB0607947D0 (en)

Priority Applications (42)

Application NumberPriority DateFiling DateTitle
GB0607947AGB0607947D0 (en)2006-04-212006-04-21Organic Compounds
DK07724372.3TDK2013211T3 (en)2006-04-212007-04-19 Purine derivatives for use as adenosine A2A receptor agonists
NZ571429ANZ571429A (en)2006-04-212007-04-19Purine derivatives for use as adenosine A2A receptor agonists
PCT/EP2007/003435WO2007121920A2 (en)2006-04-212007-04-19Purine derivatives for use as adenosin a2a receptor agonists
CN2007800231803ACN101472925B (en)2006-04-212007-04-19As adenosine A2APurine derivatives of receptor agonists
PL07724372TPL2013211T3 (en)2006-04-212007-04-19Purine derivatives for use as adenosin a2a receptor agonists
MX2008013431AMX2008013431A (en)2006-04-212007-04-19Purine derivatives for use as adenosin a2a receptor agonists.
US12/297,291US8258141B2 (en)2006-04-212007-04-19Organic compounds
BRPI0710573-8ABRPI0710573A2 (en)2006-04-212007-04-19 organic compounds, uses and processes for the preparation of said compounds as well as a pharmaceutical composition comprising them
CA002649215ACA2649215A1 (en)2006-04-212007-04-192,6,9-trisubstituted purine compounds as adenosine aza receptor modulators
EP10192555.0AEP2322525B1 (en)2006-04-212007-04-19Purine derivatives for use as adenosin A2A receptor agonists
PT101925550TPT2322525E (en)2006-04-212007-04-19Purine derivatives for use as adenosin a2a receptor agonists
ARP070101686AAR060607A1 (en)2006-04-212007-04-19 PURINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION METHOD AND USES IN OBSTRUCTIVE OR INFLAMMATORY DISEASES OF RESPIRATORY ROADS.
PL10192555TPL2322525T3 (en)2006-04-212007-04-19Purine derivatives for use as adenosin A2A receptor agonists
RU2008145716/04ARU2457209C2 (en)2006-04-212007-04-19Purine derivatives applicable as adenosine receptor a2a agonists
ES07724372TES2384337T3 (en)2006-04-212007-04-19 Purine derivatives for use as adenosine A2A receptor agonists
ES10192555.0TES2440317T3 (en)2006-04-212007-04-19 Purine derivatives for use as adenosine A2A receptor agonists
PE2007000482APE20080361A1 (en)2006-04-212007-04-19 PURINE-DERIVED COMPOUNDS AS ADENOSINE A2A RECEPTOR ACTIVATORS
AU2007241343AAU2007241343B2 (en)2006-04-212007-04-19Purine derivatives for use as adenosin A2A receptor agonists
MYPI20084072AMY146645A (en)2006-04-212007-04-19Purine derivatives for use as adenosin a2a receptor agonists
AT07724372TATE549337T1 (en)2006-04-212007-04-19 PURINE DERIVATIVES FOR USE AS ADENOSINE A2A RECEPTOR AGONISTS
UAA200811313AUA94735C2 (en)2006-04-212007-04-19Purine derivatives for use as adenosin a2a receptor agonists
JP2009505779AJP5373599B2 (en)2006-04-212007-04-19 Purine derivatives for use as adenosine A2A receptor agonists
SI200730937TSI2013211T1 (en)2006-04-212007-04-19Purine derivatives for use as adenosin a2a receptor agonists
PT07724372TPT2013211E (en)2006-04-212007-04-19Purine derivatives for use as adenosin a2a receptor agonists
EP07724372AEP2013211B1 (en)2006-04-212007-04-19Purine derivatives for use as adenosin a2a receptor agonists
KR1020087028413AKR20080110925A (en)2006-04-212007-04-19 Purine Derivatives for Use as Adenosine A2A Receptor Agonists
TW096114114ATW200808797A (en)2006-04-212007-04-20Organic compounds
CL200701131ACL2007001131A1 (en)2006-04-212007-04-20 COMPOUNDS DERIVED FROM REPLACED PURINA; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF AN INFLAMMATORY OR OBSTRUCTIVE DISEASE OF THE RESPIRATORY ROADS.
ZA200808055AZA200808055B (en)2006-04-212008-09-19Organic compounds
IL194396AIL194396A0 (en)2006-04-212008-09-25Purine derivatives for use as adenosin a2a receptor agonists
CR10335ACR10335A (en)2006-04-212008-10-01 ORGANIC COMPOUNDS
GT200800219AGT200800219A (en)2006-04-212008-10-17 PURINE DERIVATIVES TO BE USED AS ADENOSINE A2A RECEIVER AGONISTS
TNP2008000407ATNSN08407A1 (en)2006-04-212008-10-17Organic compounds
EC2008008836AECSP088836A (en)2006-04-212008-10-21 PURINE DERIVATIVES TO BE USED AS ADENOSINE A2A RECEIVER AGONISTS
MA31369AMA30469B1 (en)2006-04-212008-11-10 ORGANIC COMPOUNDS
NO20084803ANO20084803L (en)2006-04-212008-11-14 organic compounds
HK09104459.7AHK1125642A1 (en)2006-04-212009-05-15Purine derivatives for use as adenosin a2a receptor agonists
US13/218,865US8318750B2 (en)2006-04-212011-08-26Organic compounds
US13/218,887US20120004247A1 (en)2006-04-212011-08-26Organic compounds
HRP20120494TTHRP20120494T1 (en)2006-04-212012-06-12Purine derivatives for use as adenosin a2a receptor agonists
CY20121100544TCY1113063T1 (en)2006-04-212012-06-14 PURINI PRODUCTS FOR USE AS AGENTS OF ADENOSIN A2A RECEPTORS

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
GB0607947AGB0607947D0 (en)2006-04-212006-04-21Organic Compounds

Publications (1)

Publication NumberPublication Date
GB0607947D0true GB0607947D0 (en)2006-05-31

Family

ID=36581044

Family Applications (1)

Application NumberTitlePriority DateFiling Date
GB0607947ACeasedGB0607947D0 (en)2006-04-212006-04-21Organic Compounds

Country Status (4)

CountryLink
CN (1)CN101472925B (en)
GB (1)GB0607947D0 (en)
UA (1)UA94735C2 (en)
ZA (1)ZA200808055B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US20240116975A1 (en)*2020-12-292024-04-11Zhejiang Vimgreen Pharmaceuticals, Ltd.Adenosine a3 receptor agonists, preparation methods and uses thereof

Also Published As

Publication numberPublication date
UA94735C2 (en)2011-06-10
ZA200808055B (en)2009-07-29
CN101472925B (en)2012-06-13
CN101472925A (en)2009-07-01

Similar Documents

PublicationPublication DateTitle
GB0606774D0 (en)Organic compounds
GB0607950D0 (en)Organic compounds
EP2023729A4 (en)Organic compounds
GB0603684D0 (en)Organic compounds
GB0605691D0 (en)Organic Compounds
GB0606429D0 (en)Organic compounds
GB0607389D0 (en)Organic compounds
GB0605689D0 (en)Organic compounds
GB0605688D0 (en)Organic compounds
GB0605120D0 (en)Organic Compounds
GB0604937D0 (en)Organic compounds
GB0601406D0 (en)Organic Compounds
GB0602123D0 (en)Organic compounds
GB0601951D0 (en)Organic compounds
GB0606804D0 (en)Organic Compounds
GB0603782D0 (en)Organic compounds
GB0616002D0 (en)Organic compounds
GB0606562D0 (en)Organic compounds
GB0603880D0 (en)Organic compounds
GB0606202D0 (en)Organic compounds
GB0601405D0 (en)Organic Compounds
GB0600618D0 (en)Organic compounds
GB0600238D0 (en)Organic compounds
ZA200808055B (en)Organic compounds
GB0604223D0 (en)Organic compounds

Legal Events

DateCodeTitleDescription
ATApplications terminated before publication under section 16(1)
[8]ページ先頭
©2009-2025 Movatter.jp